Adipocyte-myocyte crosstalk in skeletal muscle insulin resistance; Is there a role for thyroid hormone?

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 13, Issue 6, 2010, Pages 641-646

  Havekes, Bas ^a   Sauerwein, Hans P ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

adipose tissue; crosstalk; hypothyroidism; insulin resistance; obesity; skeletal muscle; thyroid hormone

Indexed keywords

ADIPOCYTOKINE; FATTY ACID; MYOSTATIN; THYROID HORMONE;

ADIPOCYTE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INSULIN RESISTANCE; LIPOLYSIS; MOLECULAR INTERACTION; MUSCLE CELL; MUSCLE DEVELOPMENT; REVIEW; SKELETAL MUSCLE;

ADIPOCYTES; ADIPOKINES; HUMANS; INSULIN RESISTANCE; MUSCLE FIBERS, SKELETAL; MYOSTATIN; RECEPTOR CROSS-TALK; THYROID DISEASES; THYROID HORMONES;

EID: 78149284666     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32833e341d     Document Type: Review

References (52)

1. Abel ED, Peroni O, Kim JK, et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001;409:729-733.
2. De Fronzo RA, Jacot E, Jequier E, et al. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981;30:1000-1007.
3. Carvalho E, Kotani K, Peroni OD, Kahn BB. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Am J Physiol Endocrinol Metab 2005;289:E551 - E561.
4. Peppa M, Koliaki C, Nikolopoulos P, Raptis SA. Skeletal muscle insulin •• resistance in endocrine disease. J Biomed Biotechnol 2010;2010:527850. This is an excellent overview of insulin resistance in endocrine disease.
5. Sell H, Dietze-Schroeder D, Eckel J. The adipocyte-myocyte axis in insulin resistance. Trends Endocrinol Metab 2006;17:416-422.
6. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-2556.
7. Argiles JM, Lopez-Soriano J, Almendro V, et al. Cross-talk between skeletal muscle and adipose tissue: a link with obesity? Med Res Rev 2005;25:49-65.
8. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001;414:799-806.
9. Pirola L, Johnston AM, Van Obberghen E. Modulation of insulin action. Diabetologia 2004;47:170-184.
10. Odegaard JI, Chawla A. Mechanisms of macrophage activation in obesityinduced insulin resistance. Nat Clin Pract Endocrinol Metab 2008;4:619-626.
11. Dimitriadis G, Mitrou P, Lambadiari V, et al. Glucose and lipid fluxes in the adipose tissue after meal ingestion in hyperthyroidism. J Clin Endocrinol Metab 2006;91:1112-1118.
12. Dimitriadis G, Mitrou P, Lambadiari V, et al. Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol Metab 2006;91:4930-4937.
13. Amati F, Dube JJ, Stefanovic-Racic M, et al. Improvements in insulin sensitivity are blunted by subclinical hypothyroidism. Med Sci Sports Exerc 2009;41:265-269.
14. Klieverik LP, Coomans CP, Endert E, et al. Thyroid hormone effects on wholebody energy homeostasis and tissue-specific fatty acid uptake in vivo. Endocrinology 2009;150:5639-5648.
15. Baxter JD, Webb P. Thyroid hormone mimetics: potential applications in •• atherosclerosis, obesity and type 2 diabetes. Nat Rev Drug Discov 2009;8:308-320. This is an excellent review discussing potential beneficial effects of thyroid hormone analogs in atherosclerosis and obesity.
16. Fliers E, Klieverik LP, Kalsbeek A. Novel neural pathways for metabolic effects •• of thyroid hormone. Trends Endocrinol Metab 2009;21:230-236. This eloquent paper exemplifies that further elucidation of central effects of thyroid hormone may drastically improve our understanding of thyroid hormone-associated effects.
17. Heemstra KA, Soeters MR, Fliers E, et al. Type 2 iodothyronine deiodinase in •• skeletal muscle: effects of hypothyroidism and fasting. J Clin Endocrinol Metab 2009;94:2144-2150. This paper provides striking results that affect our understanding of thyroid hormone physiology in humans.
18. Mills I, Barge RM, Silva JE, Larsen PR. Insulin stimulation of iodothyronine 5'-deiodinase in rat brown adipocytes. Biochem Biophys Res Commun 1987;143:81-86.
19. Mitchell CS, Savage DB, Dufour S, et al. Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia. J Clin Invest 2010;120:1345-1354.
20. Brozinick J T Jr, Roberts BR, Dohm GL. Defective signaling through Akt-2 and - 3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance. Diabetes 2003;52:935-941.
21. Pender C, Goldfine ID, Kulp JL, et al. Analysis of insulin-stimulated insulin receptor activation and glucose transport in cultured skeletal muscle cells from obese subjects. Metabolism 2005;54:598-603.
22. Dietze D, Koenen M, Rohrig K, et al. Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. Diabetes 2002;51:2369-2376.
23. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002;32(Suppl 3):14-23.
24. Belfort R, Mandarino L, Kashyap S, et al. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 2005;54:1640-1648.
25. Vettor R, Milan G, Franzin C, et al. The origin of intermuscular adipose tissue • and its pathophysiological implications. Am J Physiol Endocrinol Metab 2009;297:987-998. This paper stresses the need to look beyond just visceral adipose tissue, intermuscular tissue may have pathophysiological consequences as well.
26. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol • Cell Endocrinol 2009;316:129-139. This is an excellent review displaying the endocrine characteristics of adipose tissue.
27. Dyck DJ. Adipokines as regulators of muscle metabolism and insulin sensitivity. Appl Physiol Nutr Metab 2009;34:396-402.
28. Sweeney G. Leptin signalling. Cell Signal 2002;14:655-663.
29. Arch JR. Central regulation of energy balance: inputs, outputs and leptin resistance. Proc Nutr Soc 2005;64:39-46.
30. Mitrou P, Boutati E, Lambadiari V, et al. Insulin resistance in hyperthyroidism: the role of IL6 and TNF alpha. Eur J Endocrinol 2009;162:121-126.
31. Ruan H, Miles PD, Ladd CM, et al. Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha: implications for insulin resistance. Diabetes 2002;51:3176-3188.
32. Sjoholm A, Nystrom T. Inflammation and the etiology of type 2 diabetes. Diabetes Metab Res Rev 2006;22:4-10.
33. Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808.
34. Heilbronn LK, Rood J, Janderova L, et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 2004;89:1844-1848.
35. Dyck DJ, Heigenhauser GJ, Bruce CR. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol (Oxf) 2006;186:5-16.
36. Graham TE, Yang Q, Bluher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552-2563.
37. Sell H, Dietze-Schroeder D, Kaiser U, Eckel J. Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology 2006;147:2458-2467.
38. Choi SH, Lee YJ, Park YJ, et al. Retinol binding protein-4 elevation is associated with serum thyroid-stimulating hormone level independently of obesity in elderly subjects with normal glucose tolerance. J Clin Endocrinol Metab 2008;93:2313-2318.
39. Eckardt K, Sell H, Taube A, et al. Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle. Diabetologia 2009;52:664-674.
40. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on musclederived interleukin-6. Physiol Rev 2008;88:1379-1406.
41. Rodgers BD, Garikipati DK. Clinical, agricultural, and evolutionary biology of myostatin: a comparative review. Endocr Rev 2008;29:513-534.
42. Hittel DS, Axelson M, Sarna N, et al. Myostatin decreases with aerobic exercise and associates with insulin resistance. Med Sci Sports Exerc 2010. [Epub ahead of print]
43. Guo T, Jou W, Chanturiya T, et al. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 2009;4: e4937.
44. Hittel DS, Berggren JR, Shearer J, et al. Increased secretion and expression of • myostatin in skeletal muscle from extremely obese women. Diabetes 2009;58:30-38. This study shows that obesity and insulin resistance are associated with elevated levels of circulating myostatin with potential detrimental metabolic effects.
45. Wilkes JJ, Lloyd DJ, Gekakis N. Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes 2009;58:1133-1143.
46. Vaughan M. An in vitro effect of triiodothyronine on rat adipose tissue. J Clin Invest 1967;46:1482-1491.
47. Iglesias P, Alvarez Fidalgo P, Codoceo R, Diez JJ. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol (Oxf) 2003;59:621-629.
48. Teixeira PF, Cabral MD, Silva NA, et al. Serum leptin in overt and subclinical hypothyroidism: effect of levothyroxine treatment and relationship to menopausal status and body composition. Thyroid 2009;19:443-450.
49. Cabanelas A, Cordeiro A, Santos Almeida NA, et al. Effect of triiodothyronine on adiponectin expression and leptin release by white adipose tissue of normal rats. Horm Metab Res 2010;42:254-60.
50. Fernandez-Real JM, Lopez-Bermejo A, Casamitjana R, Ricart W. Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J Clin Endocrinol Metab 2003;88:2714-2718.
51. Lin SY, Huang SC, Sheu WH. Circulating adiponectin concentrations were related to free thyroxine levels in thyroid cancer patients after thyroid hormone withdrawal. Metabolism 2009;59:195-199.
52. Carneiro I, Castro-Piedras I, Munoz A, et al. Hypothyroidism is associated with increased myostatin expression in rats. J Endocrinol Invest 2008;31:773-778.